- INACTIVE INGREDIENT
- ACTIVE INGREDIENT
- PURPOSE
- WARNINGS
- ASK DOCTOR
-
STOP USE
Stop use and ask a doctor if
- you have rectal bleeding or your nausea, bloating, cramping or abdominal pain gets worse.These may be sogns of a serious condition.
- you get diarrhea
- you need to use a laxative for longer than 1 week
- side effects may occur. you may report the side effects
to FDA at 1 - 800 - FDA - 1088
- KEEP OUT OF REACH OF CHILDREN
- PREGNANCY OR BREAST FEEDING
-
DOSAGE & ADMINISTRATION
Directions
-do not take more than directed unless advised by your doctor
-adults and children 17 years of age and older:
-stir and dissolve one packet (17g) in any 4 to 8 ounces of beverage (cold, hot or room temperature) and then drink
-use once a day
-use no more than 7 days
-Children 16 years of age or under: ask a doctor
- QUESTIONS
- INDICATIONS & USAGE
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
EZ2GO
polyethylene glycol 3350 powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:76470-005 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P) (POLYETHYLENE GLYCOL 3350 - UNII:G2M7P15E5P) POLYETHYLENE GLYCOL 3350 17 g in 17 g Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:76470-005-05 238 g in 1 BOTTLE; Type 0: Not a Combination Product 10/20/2012 2 NDC:76470-005-17 17 g in 1 POUCH; Type 0: Not a Combination Product 10/20/2012 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA091077 10/20/2012 Labeler - Valley Medical Products,LLC (969389407)